Skip to main content

Digital Health Market Insights - Fall 2024

Digital Health
Healthcare
Technology

Market Outlook

Digital Health Outlook

  • The digital health market continued to slide during Q3’24, with global funding totaling $3.3B, the second-lowest quarterly funding level since 2017.
  • Despite this decrease in funding, the average global deal size has increased from $11.8M in 2023 to $17.8M through Q3’24. This trend indicates that although risk aversion remains high, investors are placing larger investments on fewer, later-stage ventures.
  • We expect this theme of “focused funding” to continue through the final quarter of Q4’24, but investor sentiment for Q1’25 appears optimistic after consecutive rate cuts from the Federal Reserve.

Industry Snapshot

$3.3B global digital health funding (Q3 ’24) — 2nd-lowest since 2017

Average deal size up 51%, from $11.8M (2023) to $17.8M (2024 YTD)

Digital health M&A exits +23% QoQ, led by LetsGetChecked’s $525M acquisition of Truepill

A business infographic displaying three sets of data on the global digital health and clinical software market. Top left: A bar chart showing the average global digital health deal size (in millions) over five periods, with a peak in the second bar. Bottom left: A stacked bar chart titled "Percent of Quarterly Deals by Region" comparing five regions, where the U.S. leads with over 50% share each quarter, followed by Europe, Asia, RoW, and Canada. Right side: Three highlighted investment attributes for clinical software—undersaturated therapeutic areas, dependable revenue streams, and unique data capabilities—each with icons and brief descriptions. Bottom right: A bar chart showing steady growth in the global clinical trial management market from 2021 to 2027 (in billions).